Back to Journals » Clinical Ophthalmology » Volume 7

Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body

Authors Jacobs DJ, Grube TJ, Flynn Jr HW , Greven CM, Pathengay A, Miller D , Sanke RF, Thorman J

Received 19 February 2013

Accepted for publication 9 May 2013

Published 27 August 2013 Volume 2013:7 Pages 1727—1730


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 5

David J Jacobs,1,2 Thomas J Grube,3 Harry W Flynn Jr,4 Craig M Greven,5 Avinash Pathengay,6 Darlene Miller,4 Robert F Sanke,1,2 Joseph Thorman7

1Trinity Regional Eyecare, Minot, ND, USA; 2School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA; 3Grube Retina Clinic, Mandan, ND, USA; 4Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA; 5Department of Ophthalmology, Wake Forest University Eye Center, Winston-Salem, NC, USA; 6LV Prasad Eye Institute, Hyderabad, India; 7Rolla Eye Clinic, ND, USA

Abstract: A healthy 34-year-old man presented with Ochrobactrum intermedium endophthalmitis due to a metallic intraocular foreign body. After vitrectomy, lensectomy, removal of the metallic intraocular foreign body, intravitreal vancomycin and ceftazidime, and systemic ciprofloxacin, intraocular inflammation worsened. Repeat vitreous culture confirmed persistent endophthalmitis due to multidrug-resistant O. intermedium. The endophthalmitis successfully resolved after the administration of intravitreal moxifloxacin.

Keywords: moxifloxacin, Ochrobactrum intermedium, endophthalmitis, intraocular foreign body

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.